Patrick Finn

Patrick Finn is an accomplished executive with extensive experience in the life sciences industry. Currently serving as President and Chief Operating Officer at Twist Bioscience, as well as Independent Director and Chairman at ONI, Finn has a robust background in commercializing nucleic acid synthesis platforms and has held various leadership roles. Previous positions include Chief Commercial Officer and SVP of Commercial Operations at Twist Bioscience, Vice President of Sales and Marketing at Enzymatics, and Director of Business Development at Agilent Technologies. In addition to roles on scientific advisory boards and boards of directors at several biotech companies, Finn has significant expertise in research and development, particularly in nucleic acid purification and sequencing technologies. Finn holds a Ph.D. in Chemistry from the University of Southampton and a Bachelor's Degree in Chemistry from Heriot-Watt University.